Carcinoid Syndrome Diarrhea Treatment Market - Global Outlook and Forecast 2022-2028

March 2022 | 68 pages | ID: C18B17DB6967EN
Market Monitor Global

Abstracts

Carcinoid syndrome is a group of symptoms that can occur in patients suffering from carcinoid tumors which also called as metastatic neuroendocrine tumors. Carcinoid tumors are rare and these are slow growing tumors. Most of the tumors occur in gastrointestinal tract. According to FDA, carcinoid syndrome occurs in less than 10 percent of people suffering from carcinoid tumors, mostly after the tumor has spread to the liver. This syndrome causes overproduction of serotonin hormone which results in chronic diarrhea. Chronic diarrhea leads to malnutrition, weight loss, electrolyte imbalance and dehydration.

This report contains market size and forecasts of Carcinoid Syndrome Diarrhea Treatment in Global, including the following market information:

Global Carcinoid Syndrome Diarrhea Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Carcinoid Syndrome Diarrhea Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Chemotherapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Carcinoid Syndrome Diarrhea Treatment include Lexicon Pharmaceuticals, Novartis International, Pharmascience, Omega Laboratories, Teva Pharmaceutical Industries, Mylan, Ipsen, Sirtex Medical and BTG International. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Carcinoid Syndrome Diarrhea Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Carcinoid Syndrome Diarrhea Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Carcinoid Syndrome Diarrhea Treatment Market Segment Percentages, by Type, 2021 (%)

• Chemotherapy
• Somatostatin Analog (SSA) Therapy
• Oral Therapy

Global Carcinoid Syndrome Diarrhea Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Carcinoid Syndrome Diarrhea Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Cancer Research Institutes

Global Carcinoid Syndrome Diarrhea Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Carcinoid Syndrome Diarrhea Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Carcinoid Syndrome Diarrhea Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Carcinoid Syndrome Diarrhea Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Lexicon Pharmaceuticals
• Novartis International
• Pharmascience
• Omega Laboratories
• Teva Pharmaceutical Industries
• Mylan
• Ipsen
• Sirtex Medical
• BTG International

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Carcinoid Syndrome Diarrhea Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Carcinoid Syndrome Diarrhea Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CARCINOID SYNDROME DIARRHEA TREATMENT OVERALL MARKET SIZE

2.1 Global Carcinoid Syndrome Diarrhea Treatment Market Size: 2021 VS 2028
2.2 Global Carcinoid Syndrome Diarrhea Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Carcinoid Syndrome Diarrhea Treatment Players in Global Market
3.2 Top Global Carcinoid Syndrome Diarrhea Treatment Companies Ranked by Revenue
3.3 Global Carcinoid Syndrome Diarrhea Treatment Revenue by Companies
3.4 Top 3 and Top 5 Carcinoid Syndrome Diarrhea Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Carcinoid Syndrome Diarrhea Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Carcinoid Syndrome Diarrhea Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Carcinoid Syndrome Diarrhea Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Carcinoid Syndrome Diarrhea Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Carcinoid Syndrome Diarrhea Treatment Market Size Markets, 2021 & 2028
  4.1.2 Chemotherapy
  4.1.3 Somatostatin Analog (SSA) Therapy
  4.1.4 Oral Therapy
4.2 By Type - Global Carcinoid Syndrome Diarrhea Treatment Revenue & Forecasts
  4.2.1 By Type - Global Carcinoid Syndrome Diarrhea Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Carcinoid Syndrome Diarrhea Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Carcinoid Syndrome Diarrhea Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Carcinoid Syndrome Diarrhea Treatment Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Clinics
  5.1.4 Cancer Research Institutes
5.2 By Application - Global Carcinoid Syndrome Diarrhea Treatment Revenue & Forecasts
  5.2.1 By Application - Global Carcinoid Syndrome Diarrhea Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Carcinoid Syndrome Diarrhea Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Carcinoid Syndrome Diarrhea Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Carcinoid Syndrome Diarrhea Treatment Market Size, 2021 & 2028
6.2 By Region - Global Carcinoid Syndrome Diarrhea Treatment Revenue & Forecasts
  6.2.1 By Region - Global Carcinoid Syndrome Diarrhea Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Carcinoid Syndrome Diarrhea Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Carcinoid Syndrome Diarrhea Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Carcinoid Syndrome Diarrhea Treatment Revenue, 2017-2028
  6.3.2 US Carcinoid Syndrome Diarrhea Treatment Market Size, 2017-2028
  6.3.3 Canada Carcinoid Syndrome Diarrhea Treatment Market Size, 2017-2028
  6.3.4 Mexico Carcinoid Syndrome Diarrhea Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Carcinoid Syndrome Diarrhea Treatment Revenue, 2017-2028
  6.4.2 Germany Carcinoid Syndrome Diarrhea Treatment Market Size, 2017-2028
  6.4.3 France Carcinoid Syndrome Diarrhea Treatment Market Size, 2017-2028
  6.4.4 U.K. Carcinoid Syndrome Diarrhea Treatment Market Size, 2017-2028
  6.4.5 Italy Carcinoid Syndrome Diarrhea Treatment Market Size, 2017-2028
  6.4.6 Russia Carcinoid Syndrome Diarrhea Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Carcinoid Syndrome Diarrhea Treatment Market Size, 2017-2028
  6.4.8 Benelux Carcinoid Syndrome Diarrhea Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Carcinoid Syndrome Diarrhea Treatment Revenue, 2017-2028
  6.5.2 China Carcinoid Syndrome Diarrhea Treatment Market Size, 2017-2028
  6.5.3 Japan Carcinoid Syndrome Diarrhea Treatment Market Size, 2017-2028
  6.5.4 South Korea Carcinoid Syndrome Diarrhea Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Carcinoid Syndrome Diarrhea Treatment Market Size, 2017-2028
  6.5.6 India Carcinoid Syndrome Diarrhea Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Carcinoid Syndrome Diarrhea Treatment Revenue, 2017-2028
  6.6.2 Brazil Carcinoid Syndrome Diarrhea Treatment Market Size, 2017-2028
  6.6.3 Argentina Carcinoid Syndrome Diarrhea Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Carcinoid Syndrome Diarrhea Treatment Revenue, 2017-2028
  6.7.2 Turkey Carcinoid Syndrome Diarrhea Treatment Market Size, 2017-2028
  6.7.3 Israel Carcinoid Syndrome Diarrhea Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Carcinoid Syndrome Diarrhea Treatment Market Size, 2017-2028
  6.7.5 UAE Carcinoid Syndrome Diarrhea Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Lexicon Pharmaceuticals
  7.1.1 Lexicon Pharmaceuticals Corporate Summary
  7.1.2 Lexicon Pharmaceuticals Business Overview
  7.1.3 Lexicon Pharmaceuticals Carcinoid Syndrome Diarrhea Treatment Major Product Offerings
  7.1.4 Lexicon Pharmaceuticals Carcinoid Syndrome Diarrhea Treatment Revenue in Global Market (2017-2022)
  7.1.5 Lexicon Pharmaceuticals Key News
7.2 Novartis International
  7.2.1 Novartis International Corporate Summary
  7.2.2 Novartis International Business Overview
  7.2.3 Novartis International Carcinoid Syndrome Diarrhea Treatment Major Product Offerings
  7.2.4 Novartis International Carcinoid Syndrome Diarrhea Treatment Revenue in Global Market (2017-2022)
  7.2.5 Novartis International Key News
7.3 Pharmascience
  7.3.1 Pharmascience Corporate Summary
  7.3.2 Pharmascience Business Overview
  7.3.3 Pharmascience Carcinoid Syndrome Diarrhea Treatment Major Product Offerings
  7.3.4 Pharmascience Carcinoid Syndrome Diarrhea Treatment Revenue in Global Market (2017-2022)
  7.3.5 Pharmascience Key News
7.4 Omega Laboratories
  7.4.1 Omega Laboratories Corporate Summary
  7.4.2 Omega Laboratories Business Overview
  7.4.3 Omega Laboratories Carcinoid Syndrome Diarrhea Treatment Major Product Offerings
  7.4.4 Omega Laboratories Carcinoid Syndrome Diarrhea Treatment Revenue in Global Market (2017-2022)
  7.4.5 Omega Laboratories Key News
7.5 Teva Pharmaceutical Industries
  7.5.1 Teva Pharmaceutical Industries Corporate Summary
  7.5.2 Teva Pharmaceutical Industries Business Overview
  7.5.3 Teva Pharmaceutical Industries Carcinoid Syndrome Diarrhea Treatment Major Product Offerings
  7.5.4 Teva Pharmaceutical Industries Carcinoid Syndrome Diarrhea Treatment Revenue in Global Market (2017-2022)
  7.5.5 Teva Pharmaceutical Industries Key News
7.6 Mylan
  7.6.1 Mylan Corporate Summary
  7.6.2 Mylan Business Overview
  7.6.3 Mylan Carcinoid Syndrome Diarrhea Treatment Major Product Offerings
  7.6.4 Mylan Carcinoid Syndrome Diarrhea Treatment Revenue in Global Market (2017-2022)
  7.6.5 Mylan Key News
7.7 Ipsen
  7.7.1 Ipsen Corporate Summary
  7.7.2 Ipsen Business Overview
  7.7.3 Ipsen Carcinoid Syndrome Diarrhea Treatment Major Product Offerings
  7.7.4 Ipsen Carcinoid Syndrome Diarrhea Treatment Revenue in Global Market (2017-2022)
  7.7.5 Ipsen Key News
7.8 Sirtex Medical
  7.8.1 Sirtex Medical Corporate Summary
  7.8.2 Sirtex Medical Business Overview
  7.8.3 Sirtex Medical Carcinoid Syndrome Diarrhea Treatment Major Product Offerings
  7.8.4 Sirtex Medical Carcinoid Syndrome Diarrhea Treatment Revenue in Global Market (2017-2022)
  7.8.5 Sirtex Medical Key News
7.9 BTG International
  7.9.1 BTG International Corporate Summary
  7.9.2 BTG International Business Overview
  7.9.3 BTG International Carcinoid Syndrome Diarrhea Treatment Major Product Offerings
  7.9.4 BTG International Carcinoid Syndrome Diarrhea Treatment Revenue in Global Market (2017-2022)
  7.9.5 BTG International Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Carcinoid Syndrome Diarrhea Treatment Market Opportunities & Trends in Global Market
Table 2. Carcinoid Syndrome Diarrhea Treatment Market Drivers in Global Market
Table 3. Carcinoid Syndrome Diarrhea Treatment Market Restraints in Global Market
Table 4. Key Players of Carcinoid Syndrome Diarrhea Treatment in Global Market
Table 5. Top Carcinoid Syndrome Diarrhea Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Carcinoid Syndrome Diarrhea Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Carcinoid Syndrome Diarrhea Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Carcinoid Syndrome Diarrhea Treatment Product Type
Table 9. List of Global Tier 1 Carcinoid Syndrome Diarrhea Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Carcinoid Syndrome Diarrhea Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Carcinoid Syndrome Diarrhea Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Carcinoid Syndrome Diarrhea Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Carcinoid Syndrome Diarrhea Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Carcinoid Syndrome Diarrhea Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Carcinoid Syndrome Diarrhea Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Carcinoid Syndrome Diarrhea Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Carcinoid Syndrome Diarrhea Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Carcinoid Syndrome Diarrhea Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Carcinoid Syndrome Diarrhea Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Carcinoid Syndrome Diarrhea Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Carcinoid Syndrome Diarrhea Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Carcinoid Syndrome Diarrhea Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Carcinoid Syndrome Diarrhea Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Carcinoid Syndrome Diarrhea Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Carcinoid Syndrome Diarrhea Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Carcinoid Syndrome Diarrhea Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Carcinoid Syndrome Diarrhea Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Carcinoid Syndrome Diarrhea Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Carcinoid Syndrome Diarrhea Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Lexicon Pharmaceuticals Corporate Summary
Table 31. Lexicon Pharmaceuticals Carcinoid Syndrome Diarrhea Treatment Product Offerings
Table 32. Lexicon Pharmaceuticals Carcinoid Syndrome Diarrhea Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Novartis International Corporate Summary
Table 34. Novartis International Carcinoid Syndrome Diarrhea Treatment Product Offerings
Table 35. Novartis International Carcinoid Syndrome Diarrhea Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Pharmascience Corporate Summary
Table 37. Pharmascience Carcinoid Syndrome Diarrhea Treatment Product Offerings
Table 38. Pharmascience Carcinoid Syndrome Diarrhea Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Omega Laboratories Corporate Summary
Table 40. Omega Laboratories Carcinoid Syndrome Diarrhea Treatment Product Offerings
Table 41. Omega Laboratories Carcinoid Syndrome Diarrhea Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Teva Pharmaceutical Industries Corporate Summary
Table 43. Teva Pharmaceutical Industries Carcinoid Syndrome Diarrhea Treatment Product Offerings
Table 44. Teva Pharmaceutical Industries Carcinoid Syndrome Diarrhea Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Mylan Corporate Summary
Table 46. Mylan Carcinoid Syndrome Diarrhea Treatment Product Offerings
Table 47. Mylan Carcinoid Syndrome Diarrhea Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Ipsen Corporate Summary
Table 49. Ipsen Carcinoid Syndrome Diarrhea Treatment Product Offerings
Table 50. Ipsen Carcinoid Syndrome Diarrhea Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Sirtex Medical Corporate Summary
Table 52. Sirtex Medical Carcinoid Syndrome Diarrhea Treatment Product Offerings
Table 53. Sirtex Medical Carcinoid Syndrome Diarrhea Treatment Revenue (US$, Mn), (2017-2022)
Table 54. BTG International Corporate Summary
Table 55. BTG International Carcinoid Syndrome Diarrhea Treatment Product Offerings
Table 56. BTG International Carcinoid Syndrome Diarrhea Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Carcinoid Syndrome Diarrhea Treatment Segment by Type in 2021
Figure 2. Carcinoid Syndrome Diarrhea Treatment Segment by Application in 2021
Figure 3. Global Carcinoid Syndrome Diarrhea Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Carcinoid Syndrome Diarrhea Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Carcinoid Syndrome Diarrhea Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Carcinoid Syndrome Diarrhea Treatment Revenue in 2021
Figure 8. By Type - Global Carcinoid Syndrome Diarrhea Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Carcinoid Syndrome Diarrhea Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Carcinoid Syndrome Diarrhea Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Carcinoid Syndrome Diarrhea Treatment Revenue Market Share, 2017-2028
Figure 12. US Carcinoid Syndrome Diarrhea Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Carcinoid Syndrome Diarrhea Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Carcinoid Syndrome Diarrhea Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Carcinoid Syndrome Diarrhea Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Carcinoid Syndrome Diarrhea Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Carcinoid Syndrome Diarrhea Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Carcinoid Syndrome Diarrhea Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Carcinoid Syndrome Diarrhea Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Carcinoid Syndrome Diarrhea Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Carcinoid Syndrome Diarrhea Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Carcinoid Syndrome Diarrhea Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Carcinoid Syndrome Diarrhea Treatment Revenue Market Share, 2017-2028
Figure 24. China Carcinoid Syndrome Diarrhea Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Carcinoid Syndrome Diarrhea Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Carcinoid Syndrome Diarrhea Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Carcinoid Syndrome Diarrhea Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Carcinoid Syndrome Diarrhea Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Carcinoid Syndrome Diarrhea Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Carcinoid Syndrome Diarrhea Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Carcinoid Syndrome Diarrhea Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Carcinoid Syndrome Diarrhea Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Carcinoid Syndrome Diarrhea Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Carcinoid Syndrome Diarrhea Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Carcinoid Syndrome Diarrhea Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Carcinoid Syndrome Diarrhea Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Lexicon Pharmaceuticals Carcinoid Syndrome Diarrhea Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Novartis International Carcinoid Syndrome Diarrhea Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Pharmascience Carcinoid Syndrome Diarrhea Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Omega Laboratories Carcinoid Syndrome Diarrhea Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Teva Pharmaceutical Industries Carcinoid Syndrome Diarrhea Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Mylan Carcinoid Syndrome Diarrhea Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Ipsen Carcinoid Syndrome Diarrhea Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Sirtex Medical Carcinoid Syndrome Diarrhea Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. BTG International Carcinoid Syndrome Diarrhea Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)